Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

OBJECTIVE: Coagulopathy is one of the characteristics observed in critically ill patients with coronavirus disease 2019 (COVID‐19). Antiphospholipid antibodies (aPLs) contribute to coagulopathy, though their role in COVID‐19 remains unclear. This study was undertaken to determine the prevalence and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arthritis Rheumatol
Asıl Yazarlar: Xiao, Meng, Zhang, Yan, Zhang, Shulan, Qin, Xuzhen, Xia, Peng, Cao, Wei, Jiang, Wei, Chen, Huan, Ding, Xin, Zhao, Hua, Zhang, Hongmin, Wang, Chunyao, Zhao, Jing, Sun, Xuefeng, Tian, Ran, Wu, Wei, Wu, Dong, Ma, Jie, Chen, Yu, Zhang, Dong, Xie, Jing, Yan, Xiaowei, Zhou, Xiang, Liu, Zhengyin, Wang, Jinglan, Du, Bin, Qin, Yan, Gao, Peng, Lu, Minya, Hou, Xin, Wu, Xian, Zhu, Huadong, Xu, Yingchun, Zhang, Wen, Li, Taisheng, Zhang, Fengchun, Zhao, Yongqiang, Li, Yongzhe, Zhang, Shuyang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
COVID‐19
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361932/
https://ncbi.nlm.nih.gov/pubmed/32602200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41425
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller